Endovastec™ Minos® Stent Graft System Completes First Clinical Implantation in Hungary

Debrecen, Hungary – The Minos® Abdominal Aortic Stent-Graft and Delivery System (“Minos® Stent Graft System”), developed by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”), has successfully completed its first clinical implantation in Hungary.

The Minos® System features a three-piece design which enables flexible assembly to accommodate different size requirements. The advanced core technologies are able to meet the treatment needs of a wider range of abdominal aortic aneurysms with complex anatomy, reducing the rate of complications such as device migration, endoleaks and occlusion, thereby lowering the risk of long-term reintervention. A team led by Dr. Csaba Toth and Dr. Istvan Lazar at the University Hospital of Debrecen, Hungary, performed the pioneering procedure.

Zhenghua Miao, President of Endovastec™, said, “One year after it was introduced to the overseas market, the Minos® Stent Graft System is now widely recognized by experts for its excellent clinical performance in countries across Europe and South America, providing a better solution for patients with complex abdominal aortic anatomy. We will continue to strengthen our in-depth cooperation with clinical experts overseas, to further accelerate our reach and provide more inclusive and quality ‘Chinese solutions’ to a greater number of patients worldwide.”

As a new generation of abdominal aortic stent graft systems independently developed by Endovastec™, the Minos® Stent Graft System is designed for the interventional therapy of abdominal aortic aneurysms, with proximal neck length of no less than 15mm. Its ultra-low profile delivery system with an outer diameter of 14F (<5mm) significantly reduces the vessel access required for the endovascular aneurysm repair of abdominal aortic aneurysms, providing a better solution for patients with complex abdominal aortic anatomy, especially those with tortuous, or narrow access vessel arteries.